Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it is scheduled to join the U.S. broad-market Russell 3000 Index, which includes the 3,000 publicly traded companies on the Nasdaq and NYSE exchanges with the largest market capitalizations. According to the update and…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday reported financial results for the quarter ended March 31, 2020 and provided a business update. “We remain steadfast in our approach to assembling a portfolio of assets that leverages our unique collection of cancer…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will present at the MoneyShow June Virtual Event at 12:50 p.m. EDT on Wednesday, June 10, 2020. According to the update, Genprex’s CEO and Chairman, Rodney Varner, will deliver a company overview and…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that, due to the current impact of the COVID-19 pandemic and limitations within the state of New Mexico on all non-essential gatherings of individuals, it has changed the format of its annual stockholders meeting. According to the…
SRAX (NASDAQ: SRAX) recently held its FY 2019 and Q1 2020 results conference call (http://ibn.fm/YOcxB). An article further discussing the company’s results reads, “SRAX’s fiscal 2019 revenues of $3.6 million showed a 3% year-to-year increase while Q1 2020 sales fell to $350,000 relative to the $592,000 recorded in 2019, the latter decline largely a result…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, is strategically positioned to capitalize on the Trump administration’s recently announced plan to revitalize the U.S. nuclear energy industry (http://ibn.fm/mvTrl). An article discussing the company reads, “Trump’s proposal to spend $150 million on a strategic U.S. uranium reserve will purchase…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company’s initial manufacturing…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that it will present at the Virtual Investor Summit, slated to take place June 9-12, 2020. Sigma is scheduled to present at 11:30 a.m. Eastern Time on Wednesday, June 10, and its President and CEO Mark Ruport…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 (“FY 2020”) and management’s discussion and analysis (“MD&A”) for the three and twelve months ended March 31, 2020. “The global economic uncertainty brought on by COVID-19…
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the update, Trxade Group management is scheduled to present at 10:20 AM ET (7:20 AM PT) on Tuesday, June 9, 2020,…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively “GGB”, the “company” or the “Applicants”) on Tuesday released an update on its insolvency proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). As announced on May 20, 2020, GGB filed for insolvency protection under the CCAA…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Tuesday announced the completion of the acquisitions of two wholly owned subsidiaries of InventaBioTech, Inc., Soluble Therapeutics, Inc. and BioDtech, Inc. Included in the acquisition were certain intellectual property relating to contract research organization (“CRO”)…
Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. An article discussing the company reads, “With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own…
Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical teleconferencing visits through Bonum Health and prescription delivery through the company’s DelivMeds same day/mail-order pharmaceuticals…
Sigma Labs (NASDAQ: SGLB), a leading provider of in-process, quality-assurance software for the additive manufacturing industry, recently appointed experienced software industry executive Mark K. Ruport as CEO and president (http://ibn.fm/oNSOj). The move finalizes the company’s management transition process. An article further discussing the new appointment reads, “In his new assignment, Ruport will leverage his experience…
SRAX (NASDAQ: SRAX) recently announced the rebranding of its investor intelligence platform from SRAX IR to Sequire. An article further discussing the platform reads, “The investor-relations platform, which enables companies to monitor their shareholders’ buying and selling behavior and carry out virtual investor meetings among other services, announced that it had gained 59 corporate subscribers…
Predictive Oncology (NASDAQ: POAI) CEO Dr. Carl Schwartz recently referred to the company’s Helomics subsidiary as a “major asset” during an exclusive NNW interview with Stuart Smith (http://ibn.fm/8knZX). An article discussing the interview reads, “During the interview, Schwartz pointed out that Helomics’ collection of more than 150,000 cancer tumors is the largest inventory of its kind…
Genprex (NASDAQ: GNPX) today announced the exercise of warrants to purchase approximately 5.4 million shares of common stock issued in connection with capital raises in May 2018 and November 2019 with two institutional investors at a price of $0.46 per share, resulting in its receipt of approximately $2.5 million in cash proceeds. According to the…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its pending merger partner Cannaworx, Inc. will be launching its patented and proprietary immune booster supplement by mid-July 2020.…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) today announced its entry into a three-year partnership with smart education service provider, Sutesen Information Technology Ltd. (“Sutesen”), to expand Blue Hat’s Smart Immersive Education Classes, or “AR Immersive Classes” (“ARIC”), in Guangxi province, China. According to the update, the partnership aims to commercially launch ARIC in up…